GSK plc ADR buy Royal Bank of Canada
Start price
09.06.26
/
50%
€44.40
Target price
09.06.27
-
Performance (%)
-4.50%
Price
10:06
€42.40
Summary
This prediction is currently active. With a performance of -4.50%, the BUY prediction by Royal_Bank_of_Canada is trending in the wrong direction. This prediction currently runs until 09.06.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| GSK plc ADR | -3.524% | -3.524% |
| iShares Core DAX® | 0.881% | 5.632% |
| iShares Nasdaq 100 | 2.390% | 1.571% |
| iShares Nikkei 225® | 4.269% | 2.521% |
| iShares S&P 500 | 1.171% | 2.545% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread GSK plc ADR diskutieren
GSK (GSK) had its "outperform" rating reaffirmed by Royal Bank Of Canada.
Ratings data for GSK provided by MarketBeat

